Tumor-infiltrating lymphocytes and interleukin-2 in melanomas. Sondel PM, Sosman JA, Hank JA, Kohler PC, Storer B (1989) N Engl J Med 320: 1418-9 Viral evasion of antigen presentation: not just for peptides anymore. Van Kaer L, Joyce S (2006) Nat Immunol 7: 795-7 Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S (1994) Immunity 1: 533-41 DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer. Luo N, Nixon MJ, Gonzalez-Ericsson PI, Sanchez V, Opalenik SR, Li H, Zahnow CA, Nickels ML, Liu F, Tantawy MN, Sanders ME, Manning HC, Balko JM (2018) Nat Commun 9: 248 Vesicular stomatitis virus antigenic octapeptide N52-59 is anchored into the groove of the H-2Kb molecule by the side chains of three amino acids and the main-chain atoms of the amino terminus. Shibata K, Imarai M, van Bleek GM, Joyce S, Nathenson SG (1992) Proc Natl Acad Sci U S A 89: 3135-9 Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice. Aldrich CJ, Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Forman J (1994) Proc Natl Acad Sci U S A 91: 6525-8 Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Ravichandran KS, Igras V, Shoelson SE, Fesik SW, Burakoff SJ (1996) Proc Natl Acad Sci U S A 93: 5275-80 Antigen-specific recognition of autologous leukemia cells and allogeneic class-I MHC antigens by IL-2-activated cytotoxic T cells from a patient with acute T-cell leukemia. Fisch P, Weil-Hillman G, Uppenkamp M, Hank JA, Chen BP, Sosman JA, Bridges A, Colamonici OR, Sondel PM (1989) Blood 74: 343-53 Specific recognition of human leukemic cells by allogeneic T cells: II. Evidence for HLA-D restricted determinants on leukemic cells that are crossreactive with determinants present on unrelated nonleukemic cells. Sosman JA, Oettel KR, Smith SD, Hank JA, Fisch P, Sondel PM (1990) Blood 75: 2005-16 NKT cells: T lymphocytes with innate effector functions. Van Kaer L (2007) Curr Opin Immunol 19: 354-64 Versatile prostate cancer treatment with inducible caspase and interleukin-12. Nikitina EY, Desai SA, Zhao X, Song W, Luo AZ, Gangula RD, Slawin KM, Spencer DM (2005) Cancer Res 65: 4309-19 Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, Bander NH, Novick AC, Finke JH (1999) Clin Cancer Res 5: 1219-29 Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006) Clin Cancer Res 12: 1897-905 PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L, Dotti G, Gottschalk SM, Wilson MH, Rooney CM (2011) Mol Ther 19: 2133-43 Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, Gallo R, Vermund SH, Louria DB (2002) J Infect Dis 185: 428-38 Pillars article: antigen presentation: discovery of the peptide TAP. Van Kaer L (2008) J Immunol 180: 2723-4 Differential requirement for tapasin in the presentation of leader- and insulin-derived peptide antigens to Qa-1b-restricted CTLs. Li L, Sullivan BA, Aldrich CJ, Soloski MJ, Forman J, Grandea AG, Jensen PE, Van Kaer L (2004) J Immunol 173: 3707-15 The Ig-like domain of tapasin influences intermolecular interactions. Turnquist HR, Petersen JL, Vargas SE, McIlhaney MM, Bedows E, Mayer WE, Grandea AG, Van Kaer L, Solheim JC (2004) J Immunol 172: 2976-84 The alloreactive T cell response against the class Ib molecule H2-M3 is specific for high affinity peptides. Dabhi VM, Hovik R, Van Kaer L, Lindahl KF (1998) J Immunol 161: 5171-8 A molecular basis for how a single TCR interfaces multiple ligands. Boesteanu A, Brehm M, Mylin LM, Christianson GJ, Tevethia SS, Roopenian DC, Joyce S (1998) J Immunol 161: 4719-27 Thermolabile H-2Kb molecules expressed by transporter associated with antigen processing-deficient RMA-S cells are occupied by low-affinity peptides. De Silva AD, Boesteanu A, Song R, Nagy N, Harhaj E, Harding CV, Joyce S (1999) J Immunol 163: 4413-20 Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. Yoshimura Y, Yadav R, Christianson GJ, Ajayi WU, Roopenian DC, Joyce S (2004) J Immunol 172: 6666-74 Development of antigen-specific CD8+ CTL in MHC class I-deficient mice through CD4 to CD8 conversion. Tanaka Y, Koido S, Xia J, Ohana M, Liu C, Cote GM, Sawyer DB, Calderwood S, Gong J (2004) J Immunol 172: 7848-58 Cutting edge: distal regulatory elements are required to achieve selective expression of IFN-gamma in Th1/Tc1 effector cells. Soutto M, Zhou W, Aune TM (2002) J Immunol 169: 6664-7 NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS (2002) J Virol 76: 4294-303 Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice. Major AS, Cuff CF (1997) J Virol 71: 5782-9 Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. Venter M, Rock M, Puren AJ, Tiemessen CT, Crowe JE (2003) J Virol 77: 7319-29 Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM (2007) J Virol 81: 12382-93 Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. Kulkarni AB, Collins PL, Bacik I, Yewdell JW, Bennink JR, Crowe JE, Murphy BR (1995) J Virol 69: 1261-4 Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice. Ljunggren HG, Van Kaer L, Ashton-Rickardt PG, Tonegawa S, Ploegh HL (1995) Eur J Immunol 25: 174-8 TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity. Sandberg JK, Chambers BJ, Van Kaer L, Kärre K, Ljunggren HG (1996) Eur J Immunol 26: 288-93 Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains. Gómez-Duarte OG, Pasetti MF, Santiago A, Sztein MB, Hoffman SL, Levine MM (2001) Infect Immun 69: 1192-8 Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN (2012) Biol Blood Marrow Transplant 18: 1069-75 Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen. Xue BH, Zhang Y, Sosman JA, Peace DJ (1997) Prostate 30: 73-8 Specific recognition of human leukemic cells by allogeneic T cell lines. Sosman JA, Oettel KR, Hank JA, Fisch P, Sondel PM (1989) Transplantation 48: 486-95 Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Yang J, Jaramillo A, Liu W, Olack B, Yoshimura Y, Joyce S, Kaleem Z, Mohanakumar T (2003) Transplantation 76: 84-91 Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. Spence PM, Sriram V, Van Kaer L, Hobbs JA, Brutkiewicz RR (2001) Immunology 104: 168-74 Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Rock MT, Crowe JE (2003) Immunology 108: 474-80 Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer. Perambakam S, Xue BH, Sosman JA, Peace DJ (2002) Cancer Immunol Immunother 51: 263-70 Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Verma B, Hawkins OE, Neethling FA, Caseltine SL, Largo SR, Hildebrand WH, Weidanz JA (2010) Cancer Immunol Immunother 59: 563-73
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.